View of Evaluation of Glycemic and Hepatic Markers in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Treated with Pioglitazone

Return to Article Details Evaluation of Glycemic and Hepatic Markers in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Treated with Pioglitazone Download Download PDF